|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer using specific compounds.
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
NCT01234567
|
|
gptkbp:dosageForm
|
tablet
|
|
gptkbp:evaluates
|
demonstrated_in_Phase_II_trials
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 15, 2023
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:fieldOfUse
|
oncology
|
|
gptkbp:filingCountry
|
gptkb:USA
|
|
gptkbp:filingDate
|
March 15, 2003
|
|
gptkbp:geographicalFeature
|
gptkb:USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,028 C9
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:inventorCountry
|
gptkb:USA
|
|
gptkbp:issuedOn
|
September 7, 2004
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:marketedAs
|
Brand Y
|
|
gptkbp:material
|
Compound X
|
|
gptkbp:nonPatentCitation
|
Journal of Oncology, 2003.
|
|
gptkbp:patentClassification
|
A61K, C07D
|
|
gptkbp:patentFamily
|
Bristol-Myers_Squibb_patents
|
|
gptkbp:patentInventor
|
20 years
|
|
gptkbp:patentLitigation
|
none reported
|
|
gptkbp:patentNumber
|
6,789,028
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:publicationNumber
|
gptkb:US_2004/0180001_A1
|
|
gptkbp:relatedPatent
|
gptkb:US_6,789,027_C9
|
|
gptkbp:relatedTo
|
gptkb:US_6,123,456_B1
|
|
gptkbp:research_areas
|
anti-cancer activity
|
|
gptkbp:route
|
oral
|
|
gptkbp:safetyFeatures
|
well-tolerated
|
|
gptkbp:status
|
active
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|